36
https://pubmed.ncbi.nlm.nih.gov/38094621
The review discusses how gut microbiota and its metabolites impact immune responses in chronic hepatitis B, suggesting potential targets for future therapies.
https://pubmed.ncbi.nlm.nih.gov/38094621
The review discusses how gut microbiota and its metabolites impact immune responses in chronic hepatitis B, suggesting potential targets for future therapies.